Medical Devices
Possis' new AngioJet Ultra Thrombectomy System sees first human use
Published in Hospital Law Weekly, February 22nd, 2007
The next-generation Ultra System, which was approved by the U.S. Food and Drug Administration (FDA) in December for blood clot removal (thrombectomy), was successfully used by physicians at the Mercy Heart & Vascular Center in multiple thrombectomy procedures over the past two weeks.
"AngioJet thrombectomy has been used in our labs for several years now and this newest generation greatly improves the ease and time to set up in emergent cases. The AngioJet System continues to deliver the most...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2007-02-22)
More Articles from Hospital Law Weekly
- Breast Cancer Screening Prevention
Reports from University of Patras highlight recent research in breast cancer screening prevention - Epidemiology
Research data from Toronto Western Hospital update understanding of epidemiology - Legal Issues
National mental illness group calls for U.S. probe of Georgia state hospital deaths, abuse - Licensing Agreements
Novogen, Sante Naturelle enter patent agreement, settle patent infringement case - Medicaid
States get federal backing to build more efficient, high quality Medicaid systems - Mergers & Acquisitions
Hospira acquisition of Mayne Pharma clears U.S. antitrust review - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
